Antibiotic News and Research RSS Feed - Antibiotic News and Research

Antibiotics are drugs used to treat infections caused by bacteria and other microorganisms.
ESCMID-ASM conference aims to speed up drug development processes for drug-resistant infections

ESCMID-ASM conference aims to speed up drug development processes for drug-resistant infections

The European Society of Clinical Microbiology and Infectious Diseases and the American Society for Microbiology (ASM) are jointly organizing a conference in Vienna from 21 – 23 September 2016 to help researchers accelerate the development of new antimicrobials for drug-resistant infections. [More]
Scientists streamline total synthesis of uncialamycin drug

Scientists streamline total synthesis of uncialamycin drug

A team led by Rice University scientists has improved the production of a potent anti-tumor antibiotic known as uncialamycin. [More]
Microbial community less stable and less diverse in antibiotic-treated children

Microbial community less stable and less diverse in antibiotic-treated children

The DIABIMMUNE project followed the development of 39 Finnish infants from birth to the age of three. Half of the children received 9-15 antibiotic treatments during the research period, and the other half did not receive any such treatments. [More]
Salvage inotuzumab ozogamicin improves ALL outcomes

Salvage inotuzumab ozogamicin improves ALL outcomes

Compared with standard chemotherapy, treatment with inotuzumab ozogamicin increases the rate of complete remission and allows a higher proportion of patients with relapsed or refractory acute lymphoblastic leukaemia to subsequently receive stem-cell transplantation, research suggests. [More]
Composition of microbiota plays significant role in body's ability to accept transplanted tissue

Composition of microbiota plays significant role in body's ability to accept transplanted tissue

Researchers from the University of Chicago have shown that microbiota—the bacteria, viruses and other microbes living on the skin and in the digestive system—play an important role in the body's ability to accept transplanted skin and other organs. [More]
Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Molecular diagnostics of the future: an interview with Elaine Warburton, OBE

Firstly, a sample must be transported from the clinic to the laboratory. Simple tests may be undertaken in a small lab within the hospital or clinic, whilst complex testing such as drug susceptibility testing is often done in a large centralized laboratory many miles from the clinic [More]
Legions of immune cells play complex role to destroy Legionella bacteria

Legions of immune cells play complex role to destroy Legionella bacteria

Immunologists and microbiologists from the University of Melbourne's Bio21 Molecular Science and Biotechnology Institute and the Peter Doherty Institute for Infection and Immunity - a joint venture between the University of Melbourne and Royal Melbourne Hospital - have led a study that defined a new cell type responsible for turning the attack back on the bacteria. [More]
Delivery mode, exposure to antibiotics and feeding method linked to change in baby's microbial communities

Delivery mode, exposure to antibiotics and feeding method linked to change in baby's microbial communities

Birth by C-section, exposure to antibiotics and formula feeding slow the development and decrease the diversity of a baby's microbes through the first year of life. That is the finding of a study led by researchers from NYU Langone Medical Center and published June 15 in the journal Science Translational Medicine. [More]
NPS MedicineWise urges Australians to stop expecting antibiotics for colds and flu

NPS MedicineWise urges Australians to stop expecting antibiotics for colds and flu

With new findings launched today showing that antimicrobial use in the community in Australia is higher than in England, Canada, Norway, Denmark, Sweden and the Netherlands—and that the number of antimicrobials being prescribed in Australia continues to grow—NPS MedicineWise is again urging Australians to stop expecting antibiotics for viruses such as colds and flu. [More]
New superbug test developed by TGen-NAU receives Australian patent

New superbug test developed by TGen-NAU receives Australian patent

Antibiotic-resistant infections should be easier to detect, and hospitals could become safer, thanks to a technology developed by the Translational Genomics Research Institute and Northern Arizona University, and protected under a patent issued by Australia. [More]
New FcMBL-based pathogen-detecting assay could rapidly detect systemic infections

New FcMBL-based pathogen-detecting assay could rapidly detect systemic infections

To date, there are no methods that can quickly and accurately detect pathogens in blood to allow the diagnosis of systemic bloodstream infections that can lead to life-threatening sepsis. [More]
Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Cranberries can reduce symptomatic UTIs and avoid chronic suppressive antibiotics

Today leading experts on infectious disease and urinary tract infections (UTIs) will gather in London to discuss the alarming state of antibiotic resistance, and present findings from a landmark study that conclusively shows that cranberries can be a nutritional approach to reducing symptomatic UTIs, and as a result, may be a useful strategy to decrease worldwide use of antibiotics. [More]
Infection prevention bundles effective for reducing CLABSIs in critical care newborns

Infection prevention bundles effective for reducing CLABSIs in critical care newborns

Infection prevention bundles, a package of evidence-based guidelines implemented in unison, are effective for reducing central line-associated blood stream infections (CLABSI) in critical care newborn infants, according to a new study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America. [More]
Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

Emergence of multidrug-resistant salmonella strains increases burden of neglected diseases in Africa

"The affected countries will have a major problem if we do not manage to control salmonella bloodstream infections with new antibiotics such as ciprofloxacin," cautions Prof Jürgen May. [More]
How can we defeat drug resistance? An interview with Dr Grania Brigden

How can we defeat drug resistance? An interview with Dr Grania Brigden

The O’Neill report is a wide ranging report recognising anti-microbial resistance (AMR) as a global problem with major public health and economic significance. [More]
New electronic sensor can distinguish between dead and living bacteria cells

New electronic sensor can distinguish between dead and living bacteria cells

A new type of electronic sensor that might be used to quickly detect and classify bacteria for medical diagnostics and food safety has passed a key hurdle by distinguishing between dead and living bacteria cells. [More]
Revolutionary technology can prevent spread of hospital-acquired infections

Revolutionary technology can prevent spread of hospital-acquired infections

Nano Textile, introduces a revolutionary technology that can transfer any type of fabric to one that kills bacteria. [More]
Tiny molecular scaffolding could be key to fight against antibiotic resistance

Tiny molecular scaffolding could be key to fight against antibiotic resistance

Tiny molecular scaffolding that joins molecules together could be the key to our battle against antibiotic resistance. Research published in Bioorganic & Medicinal Chemistry Letters shows that carbon nanodot scaffolding assembled with small molecules called polyamines can kill some dangerous drug-resistant bacteria, including Acinetobacter baumanii and Klebsiella pneumonia. [More]
New experimental antibiotic can help combat MRSA infections

New experimental antibiotic can help combat MRSA infections

A new experimental antibiotic developed by a team of scientists at Rutgers University successfully treats the deadly MRSA infection and restores the efficacy of a commonly prescribed antibiotic that has become ineffective against MRSA. [More]
Pediatric diseases and treatment could have greater impact on intestinal microbial diversity

Pediatric diseases and treatment could have greater impact on intestinal microbial diversity

Tracy C. Grikscheit, MD, pediatric surgeon and principal investigator at The Saban Research Institute of Children's Hospital Los Angeles, treats a large number of young patients who require surgery for various intestinal diseases. [More]
Advertisement
Advertisement